Loading clinical trials...
Loading clinical trials...
Skills Training for Schizophrenia: Enhancing Outcomes
This study will determine the effectiveness of skills training in people with schizophrenia and the applicability of the acquired skills in the "real world."
People with schizophrenia have a large number of social and symptom management training programs available to them. Studies suggest that these training programs are effective, but their generalizability and effectiveness in outpatient settings has not been thoroughly examined. This study will examine the treatment outcomes of a skills training approach in schizophrenic individuals taking antipsychotic medication. Participants taking stable doses of risperidone, olanzapine, or quetiapine will be randomly assigned to receive either intensive symptom management and social skills training or group therapy for 12 months. A verbal memory test will be used to stratify the randomization procedure and to control for neurocognitive functioning.
Age
18 - 55 years
Sex
ALL
Healthy Volunteers
No
Hall-Brooke-The Center
Bridgeport, Connecticut, United States
Hall-Brooke Behavioral Health Services
Westport, Connecticut, United States
Start Date
April 1, 2001
Primary Completion Date
November 1, 2005
Completion Date
November 1, 2005
Last Updated
September 24, 2013
60
Estimated participants
Social skills and symptom management training
PROCEDURE
Lead Sponsor
New York State Psychiatric Institute
Collaborators
NCT07455929
NCT06740383
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions